GREGORY KNUTZEN: Open Payments
NPI 1871554170 · COLTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,467 in 348 payments from 40 companies in 2025. Trend: 2023 $7,046 · 2024 $8,460 · 2025 $9,467
Food & beverage: $8,754Education: $713
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 37 | $1,141 |
| Janssen Biotech, Inc. | 27 | $776 |
| PFIZER INC. | 19 | $530 |
| Merck Sharp & Dohme LLC | 17 | $487 |
| Astellas Pharma US Inc | 20 | $462 |
| ABBVIE INC. | 8 | $405 |
| Genentech USA, Inc. | 24 | $400 |
| SEAGEN INC. | 4 | $347 |
| Gilead Sciences, Inc. | 9 | $330 |
| E.R. Squibb & Sons, L.L.C. | 19 | $315 |
Products named: Venclexta, ERLEADA, KEYTRUDA, ENHERTU, Trodelvy, OPDIVO, BESREMI, Lenvima.
Industry payments across CA — which companies pay providers there.
